Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela F Caveney

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Neuropsychiatric Disease and Treatment|August 30, 2008
Preliminary effects of pagoclone, a partial GABA(A) agonist, on neuropsychological performanceAngela F Caveney, Bruno Giordani, George M Haig
Public Health Reports (Washington, D.C. : 1974)|April 28, 2006
Use of death certificates to study ethnic-specific mortalityAngela F Caveney, Melinda A Smith, Lewis B Morgenstern, et al.
Human Psychopharmacology|May 25, 2005
A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolamPeter J Snyder, John Werth, Bruno Giordani, et al.
Psychopharmacology|March 31, 2006
A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolamPaul Maruff, John Werth, Bruno Giordani, et al.
BMC Health Services Research|February 23, 2010
Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort studyAngela F Caveney, Robert Silbergleit, Shirley Frederiksen, et al.
Stroke|August 7, 2010
Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with strokeWilliam J Meurer, Angela F Caveney, Alex Lo, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 12, 2010
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activatorWilliam J Meurer, Phillip A Scott, Angela F Caveney, et al.
Stroke|April 14, 2007
Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhageSatwant K Samra, Bruno Giordani, Angela F Caveney, et al.
Journal of Neurotrauma|March 15, 2016
Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain InjuryFelicia C Goldstein, Angela F Caveney, Vicki S Hertzberg, et al.
American Journal of Surgery|December 25, 2007
Surgeons outperform normative controls on neuropsychologic tests, but age-related decay of skills persistsZackary Boom-Saad, Scott A Langenecker, Linas A Bieliauskas, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neuropsychiatric Disease and Treatment|August 30, 2008
Preliminary effects of pagoclone, a partial GABA(A) agonist, on neuropsychological performanceAngela F Caveney, Bruno Giordani, George M Haig
Public Health Reports (Washington, D.C. : 1974)|April 28, 2006
Use of death certificates to study ethnic-specific mortalityAngela F Caveney, Melinda A Smith, Lewis B Morgenstern, et al.
Human Psychopharmacology|May 25, 2005
A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolamPeter J Snyder, John Werth, Bruno Giordani, et al.
Psychopharmacology|March 31, 2006
A statistical approach for classifying change in cognitive function in individuals following pharmacologic challenge: an example with alprazolamPaul Maruff, John Werth, Bruno Giordani, et al.
BMC Health Services Research|February 23, 2010
Resource utilization and outcome at a university versus a community teaching hospital in tPA treated stroke patients: a retrospective cohort studyAngela F Caveney, Robert Silbergleit, Shirley Frederiksen, et al.
Stroke|August 7, 2010
Lack of association between pretreatment neurology consultation and subsequent protocol deviation in tissue plasminogen activator-treated patients with strokeWilliam J Meurer, Angela F Caveney, Alex Lo, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 12, 2010
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activatorWilliam J Meurer, Phillip A Scott, Angela F Caveney, et al.
Stroke|April 14, 2007
Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhageSatwant K Samra, Bruno Giordani, Angela F Caveney, et al.
Journal of Neurotrauma|March 15, 2016
Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain InjuryFelicia C Goldstein, Angela F Caveney, Vicki S Hertzberg, et al.
American Journal of Surgery|December 25, 2007
Surgeons outperform normative controls on neuropsychologic tests, but age-related decay of skills persistsZackary Boom-Saad, Scott A Langenecker, Linas A Bieliauskas, et al.
Pageof 2